GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Callitas Health Inc (OTCPK:MPHMF) » Definitions » Cash Flow from Discontinued Operations

Callitas Health (Callitas Health) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Sep. 2020)


View and export this data going back to 2008. Start your Free Trial

What is Callitas Health Cash Flow from Discontinued Operations?

Cash flow from discontinued operations is the cash received by a company that comes from the sale of part of business.

Callitas Health's cash flow from discontinued operations for the three months ended in Sep. 2020 was $0.00 Mil. It means Callitas Health received $0.00 Mil from the sale of part of business quarterly. Callitas Health's cash flow from discontinued operations for the trailing twelve months (TTM) ended in Sep. 2020 was $0.00 Mil.


Callitas Health Cash Flow from Discontinued Operations Historical Data

The historical data trend for Callitas Health's Cash Flow from Discontinued Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Callitas Health Cash Flow from Discontinued Operations Chart

Callitas Health Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Cash Flow from Discontinued Operations
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Callitas Health Quarterly Data
Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20
Cash Flow from Discontinued Operations Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Callitas Health Cash Flow from Discontinued Operations Calculation

Cash received by a company that comes from the sale of part of business.

Cash Flow from Discontinued Operations for the trailing twelve months (TTM) ended in Sep. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Callitas Health Cash Flow from Discontinued Operations Related Terms

Thank you for viewing the detailed overview of Callitas Health's Cash Flow from Discontinued Operations provided by GuruFocus.com. Please click on the following links to see related term pages.


Callitas Health (Callitas Health) Business Description

Industry
Traded in Other Exchanges
N/A
Address
734 - 1055 Dunsmuir Street, Vancouver, BC, CAN, V7X 1B1
Callitas Health Inc is a clinical-stage company. It is engaged in developing technologies for the monitoring and treatment of obesity, diabetes, and other gastroenterological indications. The company's products offering includes ToConceive, C-103 Reformulated Orlistat, and Extrinsa. ToConceive is a fertility enhancing moisturizer. It is clinically proven to increase a woman's own natural conception lubrication, called transudate, to aid in conception. Orlistat is FDA-approved for weight management and sold by Roche as Xenical (prescription) and by GlaxoSmithKline as alli. Extrinsa focuses on women with orgasm and arousal difficulties. The topical, local, and the non-systemic product is also non-hormonal and does not affect the central nervous system.